Literature DB >> 23657418

Clinical and imagiological findings of central giant cell lesion and cherubism.

Lucas R Pinheiro1, João J V Pinheiro, Sérgio A Júnior, Newton Guerreiro, Marcelo G P Cavalcanti.   

Abstract

Cone beam computed tomography (CBCT) is the best examination for bone lesions of the maxilla, allowing the dentist to evaluate precisely the behavior and components of the lesion and their relationship to the surrounding structures. Central giant cell lesion and cherubism are histologically very similar lesions. Therefore clinical and radiological examinations are fundamentally important for the diagnosis. The aim of this paper is to report two cases diagnosed as central giant cell lesions and cherubism using CBCT. This imaging modality was very important for the diagnosis of the lesions presented in the current study. It also allowed observing precisely the limits of the lesions, the components, the behavior and the exact relationship to adjacent structures.

Mesh:

Year:  2013        PMID: 23657418     DOI: 10.1590/0103-6440201301861

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  4 in total

1.  Cherubism misdiagnosed as giant cell tumor: a case report and review of literature.

Authors:  Yang Jiao; Mi Zhou; Yaowu Yang; Jun Zhou; Xiaohong Duan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.

Authors:  Mario Pérez-Sayáns; Francisco Barros-Angueira; Jos Ém Suárez-Peñaranda; Abel García-García
Journal:  Head Face Med       Date:  2013-11-05       Impact factor: 2.151

Review 3.  Lumps and Bumps of the Gingiva: A Pathological Miscellany.

Authors:  Daniel J Brierley; Hannah Crane; Keith D Hunter
Journal:  Head Neck Pathol       Date:  2019-01-29

4.  Cherubism With Bilateral Mandible and Maxilla Involvement: A Case Report.

Authors:  Zhaoyang Yu; Miao Zhai; Wei Gan; Hong Zhang; Yuxia Zhou; Haixia Wen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.